NR3C1 and neoplasm: It was discovered that with tumor progression GR is translocated to the cytoplasm and its amount in the nucleus is significantly lower than in normal breast cells, surprisingly, this correlates positively with lower level of COX-2 (normally, GR represses COX-2).